An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer

被引：0
|
作者：
H E Lee
J H Kim
Y J Kim
S Y Choi
S-W Kim
E Kang
I Y Chung
I A Kim
E J Kim
Y Choi
H S Ryu
S Y Park
机构：
[1] Seoul National University Hospital,Department of Pathology
[2] Seoul National University College of Medicine,Department of Internal Medicine
[3] Seoul National University College of Medicine,Department of Surgery
[4] Breast Care Center,Department of Radiation Oncology
[5] Seoul National University Bundang Hospital,Department of Pathology
[6] 300 Gumi-dong,Department of Pathology
[7] Bundang-gu,undefined
[8] Seongnam-si,undefined
[9] Gyeonggi 463-707,undefined
[10] Korea,undefined
[11] Seoul National University College of Medicine,undefined
[12] Seoul National University Bundang Hospital,undefined
[13] Seoul National University College of Medicine,undefined
来源：
British Journal of Cancer | 2011年 / 104卷
关键词：
breast cancer; cancer stem cells; primary systemic therapy; chemoresistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1730 / 1738
页数：8
相关论文
共 50 条
  • [41] Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients
    Sven Becker
    Erich Solomayer
    Graziella Becker-Pergola
    Diethelm Wallwiener
    Tanja Fehm
    Breast Cancer Research and Treatment, 2007, 106
  • [42] Primary systemic therapy in breast cancer: clinical and molecular factors predictors of outcome and response
    Lerebours, F.
    PATHOLOGIE BIOLOGIE, 2006, 54 (04): : 209 - 214
  • [43] Can we tailor neoadjuvant (primary) systemic therapy for breast cancer?
    Eniu, A.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2008, 1 (03) : 143 - 147
  • [44] Can we tailor neoadjuvant (primary) systemic therapy for breast cancer?
    A. Eniu
    memo - Magazine of European Medical Oncology, 2008, 1 (3) : 143 - 147
  • [45] Is Season a Prognostic Factor in Breast Cancer?
    Mutlu, Hasan
    Akca, Zeki
    Cihan, Yasemin Benderli
    Kurnaz, Fatih
    Aslan, Tuncay
    Erden, Abdulsamet
    Ugur, Hediye
    Aksahin, Arzu
    Buyukcelik, Abdullah
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (02) : 743 - 746
  • [46] Age as a prognostic factor in breast cancer
    Vanlemmens, L
    Hebbar, M
    Peyrat, JP
    Bonneterre, J
    ANTICANCER RESEARCH, 1998, 18 (3B) : 1891 - 1896
  • [47] The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors
    Fonseca, Nuno A.
    Cruz, Ana Filipa
    Moura, Vera
    Simoes, Sergio
    Moreira, Joao Nuno
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 113 : 111 - 121
  • [48] Extirpating the cancer stem cell hydra: Differentiation therapy and Hyperthermia therapy for targeting the cancer stem cell hierarchy
    Tewari, Amit B.
    Saini, Anamika
    Sharma, Deepika
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (07) : 3125 - 3145
  • [49] Vav3 oncogene is upregulated and a poor prognostic factor in breast cancer patients
    Chen, Xin
    Chen, Si
    Liu, Xiao-An
    Zhou, Wen-Bin
    Ma, Rui-Rui
    Chen, Lin
    ONCOLOGY LETTERS, 2015, 9 (05) : 2143 - 2148
  • [50] Editorial: Cancer stem cells as attractive targets for breast cancer therapy
    Ibrahim, Sherif Abdelaziz
    Yip, George W.
    Goette, Martin
    FRONTIERS IN ONCOLOGY, 2023, 13
12345